|
CLONDIAG chip technologies Gmbh became part of Inverness Medical Innovations in early 2006 but was established in JENA, Germany in 1998.
CLONDIAG is at the forefront of the research of novel assay systems and has developed and manufactured a new generation of fast and innovative multiplex (allows detection of multiple analytes in a single tube or well) assays in the field of nucleic acid and immunodiagnostics.
The core of the current products is based around the array tube or the array microwell strip, both of which at their heart, have an array of up to 400 immobilised probes. Addition, processing and measurement systems are available to complement the array assays. These include the ArrayTube® readers and Microwell ArrayStrip processors.
Multiplex assays have already been developed for the following:
The technology has enormous potential and limitless
applications, so through CLONDIAG®, Inverness Medical Innovations is interested
in collaborating with academia and industry to ensure that novel new IVD
products are made available to the diagnostic marketplace to advance worldwide
healthcare.
For further information contact www.clondiag.com
|